Kodiak Sciences Inc Common Stock

Go to Kodiak Sciences Inc Common Stock Website

$3.21

(%)
Live
Previous Close

$3.21

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$168.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subje...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Kodiak (KOD) initiates a phase III study evaluating tarcocimab in diabetic retinopathy, which is expected to serve as the basis for a regulatory filing for three eye disease indications.

Related tickers: REGN, BAYRY, ADMA, KOD.

Read Full Article

Kodiak (KOD) reports a wider-than-expected loss for fourth-quarter 2023. The company provides updates regarding its pipeline development plans.

Related tickers: VNDA, ANIP, ADMA, KOD.

Read Full Article
Trending Tickers
DATS

XNAS

$1.25
(%)
LASE

XNAS

$1.94
(%)
BFRG

XNAS

$3.14
(%)
BMR

XNAS

$5.52
(%)
MLGO

XNAS

$0.00
(%)